Xyosted — Medica
Hypogonadism (primary or secondary) in males
Initial criteria
- Approve for 1 year if ONE of the following:
- A) Initial therapy – ALL of the following (i, ii, iii):
- i. Patient has persistent signs and symptoms of androgen deficiency (pre-treatment) AND
- ii. Two pre-treatment serum testosterone (total or bioavailable) measurements taken in the morning on two separate days AND
- iii. Both values are low per normal laboratory reference values;
- OR
- B) Patient currently receiving testosterone therapy – BOTH of the following:
- i. Patient has persistent signs and symptoms of androgen deficiency (pre-treatment) AND
- ii. At least one pre-treatment serum testosterone (total or bioavailable) level was low per normal laboratory reference values.
Approval duration
1 year